about
Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseasesMucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapyNADPH oxidase-driven phagocyte recruitment controls Candida albicans filamentous growth and prevents mortalityEndemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndromeCell Intrinsic Galectin-3 Attenuates Neutrophil ROS-Dependent Killing of Candida by Modulating CR3 Downstream Syk Activation.IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status.Is human Dectin-1 Y238X gene polymorphism related to susceptibility to recurrent vulvovaginal candidiasis?Effective photosensitization and selectivity in vivo of Candida Albicans by meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylatePrimary immunodeficiency diagnosed at autopsy: a case reportRasamsonia argillacea species complex: taxonomy, pathogenesis and clinical relevance.Dectin-1: a role in antifungal defense and consequences of genetic polymorphisms in humans.Incidence and anatomic localization of oral candidiasis in patients with AIDS hospitalized in a public hospital in Belo Horizonte, MG, Brazil.Chronic granulomatous disease: a review of the infectious and inflammatory complications.Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infectionsImmunosuppression, peripheral inflammation and invasive infection from endogenous gut microbiota activate retinal microglia in mouse models.Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.DAMP signaling in fungal infections and diseases.The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrumInborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.Susceptibility testing and molecular classification of Paecilomyces spp.Controlling pathogenic inflammation to fungi.Genetic Susceptibility to Fungal Infections: What is in the Genes?Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus.Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes.The HOG pathway is critical for the colonization of the mouse gastrointestinal tract by Candida albicansIdentification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responsesGastrointestinal manifestations in primary immune disorders.Attending to warning signs of primary immunodeficiency diseases across the range of clinical practiceRole of neutrophils in IL-17-dependent immunity to mucosal candidiasis.Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy.Safety, Efficacy, and Exposure-Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis.Innate antifungal immunity: the key role of phagocytes.Cracking the Toll-like receptor code in fungal infections.Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy.Invasive aspergillosis in children with acquired immunodeficiencies.Induction of protective immunity against cryptococcosis.Non-Aspergillus fungal infections in chronic granulomatous disease.Cryptococcus antigens and immune responses: implications for a vaccine.Structural and functional properties of the Trichosporon asahii glucuronoxylomannan.
P2860
Q26863260-1DB5587D-9B2A-462C-A48F-A23AFD191FCAQ27010562-13095F39-B198-4F72-A715-8C3754460E1DQ27332534-378F23CE-555B-45AC-9C33-778330B9BA4DQ28084749-C9D889E8-C009-47FB-B61F-A959BB0711D3Q30837287-9B45FBA8-5C82-4D8C-9E2D-4E65DB6B0357Q33585837-D58CE488-BD5E-474B-AB7C-40DCCD9C5BB0Q33851288-962AB314-5122-4ACD-AB3E-1023314BFF34Q33875368-D6700065-EAF0-4858-BC4A-96D48A240A58Q33890601-BC0E205A-E0F2-4F6E-9FDF-C09313C1EB28Q34360893-F0284599-ADFF-4810-A8B3-8B72B27722EAQ34520982-6CCC0CC3-E53B-41D1-85E5-A5BD94621E97Q35081946-67D3DE1A-B87C-411C-ACC4-9127040A86EDQ35084276-9AD9CAAA-EE84-4EBB-BF22-3ED05FDD2A2EQ35797419-F42DE8F2-1BD1-4B30-81D7-863C12F8D78EQ36088090-E4FE1F48-187B-4F70-8D71-12CF3505C6D7Q36192774-EFEA9B49-82E4-4CA0-A17F-9C88B94718FBQ36220396-6395D92F-D259-4702-9508-83C118E1E774Q36399747-5D826F3E-ADC7-4CFD-B3F7-8B6826D340FCQ36512728-4976D883-A7AB-4C6B-96DA-4F43BC47B559Q36804026-2E57C0EF-68D6-4073-BD79-418CB9147092Q37014666-F9D06ED0-C5DB-4972-B056-C748731B9718Q37183884-6961182A-9CFD-492A-AEAF-5AC26F060C8EQ37204164-813CDA97-FBC7-40A0-A334-A4AE4FCE76DFQ37238684-B1007BD4-DDCE-4533-BF25-19727031379BQ37441210-03E559CE-E1C3-4382-B6EC-2EA435615400Q37521076-0D67E1C5-A8BA-401D-A5B6-6B1EA49251E9Q37562226-DB5A3062-A189-4C02-93C2-E968AB19A932Q37564321-9DF3C1A7-6E7F-4A21-B005-F2D69B1D857BQ37595906-002FCC13-F63A-491B-B896-EADD4B97E306Q37624083-836ED9EA-A6B8-4557-8A78-EBFE56E6708FQ37682908-B0158740-CAB9-4692-8DDC-DD75332A1043Q37693296-227C25C0-BD11-483A-84B2-30915458821AQ37799378-9090ACE2-F079-4585-AC85-E69B3EC6D94FQ37800920-24A0FAB8-053E-46D2-98C4-0A419411FEE1Q37889382-112283E9-4DCF-4749-89AC-14800C60C4AAQ37954958-150DAC4C-060E-4481-9D2A-ADCD502F15C9Q37965038-02C5F152-16F1-4D7E-BE52-4314C70D89CCQ38078056-A6CB2839-8740-4B39-9794-56BDEFF017E1Q38155197-3C0209E5-1A30-4188-A1EC-EF8A6C3EBD0FQ39873096-454D64C6-B9D7-4266-9DF8-063101F0D1E4
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Fungal infections in primary immunodeficiencies.
@en
type
label
Fungal infections in primary immunodeficiencies.
@en
prefLabel
Fungal infections in primary immunodeficiencies.
@en
P2860
P1476
Fungal infections in primary immunodeficiencies.
@en
P2093
Charalampos Antachopoulos
Thomas J Walsh
P2860
P2888
P304
P356
10.1007/S00431-007-0527-7
P577
2007-06-06T00:00:00Z